Caption Management, LLC Neurocrine Biosciences Inc Call Options Transaction History

Caption Management, LLC

$5.74 Billion
Q3 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$114.58 - $153.15 $2.88 Million - $3.84 Million	25,100 Added 167.33%	40,100 $4.62 Million
Q2 2024 Aug 14, 2024	BUY	$130.86 - $143.19 $1.96 Million - $2.15 Million	15,000 New	15,000 $2.07 Million
Q4 2023 Feb 14, 2024	SELL	$106.07 - $132.76 $530,350 - $663,800	-5,000 Reduced 8.33%	55,000 $7.25 Million
Q3 2023 Nov 14, 2023	BUY	$94.02 - $117.1 $1.41 Million - $1.76 Million	15,000 Added 33.33%	60,000 $6.75 Million
Q2 2023 Aug 14, 2023	BUY	$89.53 - $104.87 $1.34 Million - $1.57 Million	15,000 Added 50.0%	45,000 $4.24 Million
Q1 2023 May 15, 2023	BUY	$94.11 - $123.02 $470,550 - $615,100	5,000 Added 20.0%	30,000 $3.04 Million
Q4 2022 Feb 14, 2023	SELL	$106.72 - $127.06 $384,192 - $457,416	-3,600 Reduced 12.59%	25,000 $2.99 Million
Q3 2022 Nov 14, 2022	SELL	$92.03 - $107.81 $2.43 Million - $2.85 Million	-26,400 Reduced 48.0%	28,600 $3.04 Million
Q2 2022 Aug 15, 2022	SELL	$75.79 - $100.07 $2.65 Million - $3.5 Million	-35,000 Reduced 38.89%	55,000 $5.36 Million
Q1 2022 May 13, 2022	SELL	$72.45 - $94.81 $1.45 Million - $1.9 Million	-20,000 Reduced 18.18%	90,000 $8.44 Million
Q4 2021 Feb 11, 2022	BUY	$79.65 - $106.22 $1.59 Million - $2.12 Million	20,000 Added 22.22%	110,000 $9.37 Million
Q3 2021 Nov 12, 2021	BUY	$86.18 - $99.03 $2.59 Million - $2.97 Million	30,000 Added 50.0%	90,000 $8.63 Million
Q2 2021 Aug 16, 2021	BUY	$89.43 - $102.27 $2.68 Million - $3.07 Million	30,000 Added 100.0%	60,000 $5.84 Million
Q2 2020 Aug 14, 2020	SELL	$85.09 - $130.36 $3.4 Million - $5.21 Million	-40,000 Reduced 57.14%	30,000 $3.66 Million
Q1 2020 May 15, 2020	BUY	$75.11 - $113.76 $3.38 Million - $5.12 Million	45,000 Added 180.0%	70,000 $6.06 Million
Q4 2019 Feb 13, 2020	BUY	$86.8 - $118.57 $2.17 Million - $2.96 Million	25,000 New	25,000 $2.69 Million
Q3 2019 Nov 14, 2019	SELL	$83.82 - $101.5 $2.51 Million - $3.05 Million	-30,000 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$72.24 - $91.27 $541,800 - $684,525	7,500 Added 33.33%	30,000 $2.53 Million
Q1 2019 May 14, 2019	BUY	$69.31 - $91.53 $1.56 Million - $2.06 Million	22,500 New	22,500 $1.98 Million

Others Institutions Holding NBIX

# of Institutions

626

Shares Held

94M

Call Options Held

632K

Put Options Held

621K

Black Rock Inc. New York, NY

14.2M
Shares

$1.92 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$1.35 Billion
0.02% of portfolio
State Street Corp Boston, MA

5.15M
Shares

$697 Million
0.02% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.57M
Shares

$349 Million
0.47% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.86M
Shares

$252 Million
3.62% of portfolio

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Account